46 research outputs found
Outcomes of Salvage Arthrodesis and Arthroplasty for Failed Osteochondral Allograft Transplantation of the Ankle
Background: Osteochondral allograft (OCA) transplantation is a useful treatment for posttraumatic ankle arthritis
in young patients, but failure rates are high and reoperations are not uncommon. The aim of this study was to
evaluate the outcomes of failed ankle OCA transplantation converted to ankle arthrodesis (AA) or total ankle
arthroplasty (TAA).
Methods: We evaluated 24 patients who underwent salvage procedures (13 AA and 11 TAA) after primary failed ankle
OCA transplantation. Reoperations were assessed. Failure of the salvage procedure was defined as an additional surgery
that required a revision AA/TAA or amputation. Evaluation among nonfailing ankles included the American Academy of
Orthopaedic Surgeons Foot and Ankle Module (AAOS-FAM), pain, and satisfaction.
Results: In the salvage AA cohort, 3 patients were classified as failures (2 revision AA and 1 amputation). The 10 nonfailing
patients had a mean follow-up of 7.4 years. Eighty-eight percent were satisfied with the procedure, but 63% reported
continued problems with their ankle (eg, pain, swelling, stiffness). Mean pain level was 1.9 and AAOS-FAM core score was
83±13. In the salvage TAA cohort, 2 patients were classified as failures (both revision TAA). The 9 nonfailing patients had
a mean follow-up of 3.8 years. Fifty percent were satisfied with the procedure, but 40% reported continued problems with
their ankle. The mean pain level was 1.3, and the median AAOS-FAM core score was 82±26.
Conclusion: Revision and reoperation rates for salvage procedures following failed OCA transplantation of the ankle are
higher compared to published data for primary AA and TAA procedures. However, we believe OCA transplantation can
serve as an interim procedure for younger patients with advanced ankle joint disease who may not be ideal candidates for
primary AA or TAA at the time of initial presentation.
Level of Evidence: Level IV, case series
1861-11-02 D.M. Howard, David Bugbee, and William Arnold invite Governor Washburn to event for John Goddard
https://digitalmaine.com/cw_me_1st_cav/1168/thumbnail.jp
Accuracy of Implant Placement Utilizing Customized Patient Instrumentation in Total Knee Arthroplasty
Customized patient instrumentation (CPI) combines preoperative planning with customized cutting jigs to position and align implants during total knee arthroplasty (TKA). We compared postoperative implant alignment of patients undergoing surgery with CPI to traditional TKA instrumentation for accuracy of implant placement. Twenty-five consecutive TKAs using CPI were analyzed. Preoperative CT scans of the lower extremities were segmented using a computer program. Limb alignment and mechanical axis were computed. Virtual implantation of computer-aided design models was done. Postoperative coronal and sagittal view radiographs were obtained. Using 3D image-matching software, relative positions of femoral and tibial implants were determined. Twenty-five TKAs implanted using traditional instrumentation were also analyzed. For CPI, difference in alignment from the preoperative plan was calculated. In the CPI group, the mean absolute difference between the planned and actual femoral placements was 0.67° in the coronal plane and 1.2° in the sagittal plane. For tibial alignment, the mean absolute difference was 0.9° in the coronal plane and 1.3° in the sagittal plane. For traditional instrumentation, difference from ideal placement for the femur was 1.5° in the coronal plane and 2.3° in the sagittal plane. For the tibia, the difference was 1.8° in the coronal plane. CPI achieved accurate implant positioning and was superior to traditional TKA instrumentation
A Review of Commercially Available Point-of-Care Devices to Concentrate Bone Marrow for the Treatment of Osteoarthritis and Focal Cartilage Lesions
Mesenchymal stem cells (MSCs) are a promising cell-based therapy treatment option for several orthopedic indications. Because culture expansion of MSC is time and cost intensive, a bedside concentration of bone marrow (BM) aspirate is used as an alternative. Many commercial systems are available but the available literature and knowledge regarding these systems is limited. We compared different point-of-care devices that concentrate BM (BMC) by focusing on technical features and quality parameters to help surgeons make informed decisions while selecting the appropriate device
Outcomes of Salvage Arthrodesis and Arthroplasty for Failed Osteochondral Allograft Transplantation of the Ankle
Background: Osteochondral allograft (OCA) transplantation is a useful treatment for posttraumatic ankle arthritis
in young patients, but failure rates are high and reoperations are not uncommon. The aim of this study was to
evaluate the outcomes of failed ankle OCA transplantation converted to ankle arthrodesis (AA) or total ankle
arthroplasty (TAA).
Methods: We evaluated 24 patients who underwent salvage procedures (13 AA and 11 TAA) after primary failed ankle
OCA transplantation. Reoperations were assessed. Failure of the salvage procedure was defined as an additional surgery
that required a revision AA/TAA or amputation. Evaluation among nonfailing ankles included the American Academy of
Orthopaedic Surgeons Foot and Ankle Module (AAOS-FAM), pain, and satisfaction.
Results: In the salvage AA cohort, 3 patients were classified as failures (2 revision AA and 1 amputation). The 10 nonfailing
patients had a mean follow-up of 7.4 years. Eighty-eight percent were satisfied with the procedure, but 63% reported
continued problems with their ankle (eg, pain, swelling, stiffness). Mean pain level was 1.9 and AAOS-FAM core score was
83±13. In the salvage TAA cohort, 2 patients were classified as failures (both revision TAA). The 9 nonfailing patients had
a mean follow-up of 3.8 years. Fifty percent were satisfied with the procedure, but 40% reported continued problems with
their ankle. The mean pain level was 1.3, and the median AAOS-FAM core score was 82±26.
Conclusion: Revision and reoperation rates for salvage procedures following failed OCA transplantation of the ankle are
higher compared to published data for primary AA and TAA procedures. However, we believe OCA transplantation can
serve as an interim procedure for younger patients with advanced ankle joint disease who may not be ideal candidates for
primary AA or TAA at the time of initial presentation.
Level of Evidence: Level IV, case series
Osteochondral Allograft Transplantation for Osteochondral Lesions of the Talus: Midterm Follow-up
Background: Fresh osteochondral allograft (OCA) transplantation represents a biologic restoration technique as an
alternative treatment option for larger osteochondral lesions of the talus (OLT). The purpose of this study was to evaluate
midterm outcomes after OCA transplantation for the treatment of OLT.
Methods: Nineteen patients (20 ankles) received partial unipolar OCA transplant for symptomatic OLT between January
1998 and October 2014. The mean age was 34.7 years, and 53% were male. The average graft size was 3.8 cm2. All patients
had a minimum follow-up of 2 years. Outcomes included the American Academy of Orthopaedic Surgeons Foot and Ankle
Module (AAOS-FAM), the Olerud-Molander Ankle Score (OMAS), and pain and satisfaction questionnaires. Failure of
OCA was defined as conversion to arthrodesis or revision OCA transplantation.
Results: Five of 20 ankles (25%) required further surgery, of which 3 (5%) were considered OCA failures (2 arthrodesis and
1 OCA revision). The mean time to failure was 3.5 (range, 0.9 to 6.7) years. Survivorship was 88.7% at 5 years and 81.3% at
10 years. The median follow-up of the 17 patients with grafts in situ was 9.7 years. The mean OMAS improved significantly
from 40 points preoperatively to 71 points postoperatively (P < .05; range, 5 to 55). The mean postoperative AAOS-FAM
core score was 81.5 ± 15 (range, 40.5 to 96.6). Fifteen of 17 patients responded to follow-up questions regarding their ankle;
14 patients reported less pain and better function, and 13 patients were satisfied with the results of the procedure.
Conclusion: Our study of midterm results after OCA transplantations showed that this procedure was a reasonable
treatment option for large OLT.
Level of Evidence: Level IV, case series
Fresh Osteochondral Allograft Transplantation for Fractures of the Knee
Objective The purpose of this study was to evaluate functional outcomes and allograft survivorship among patients with knee fracture who underwent fresh osteochondral allograft (OCA) transplantation as a salvage treatment option. Design Retrospective analysis of prospectively collected data. Setting Department of Orthopaedic Surgery at one hospital. Patients Fresh OCAs were implanted for osteochondral lesions after knee fracture in 24 males and 15 females with an average age of 34 years. Twenty-nine lesions (74%) were tibial plateau fractures, 6 (15%) were femoral condyle fractures, and 4 (10%) were patella fractures. Main Outcome Measurements Clinical evaluation included modified Merle d'Aubigne-Postel (18-point), International Knee Documentation Committee, and Knee Society function scores, and patient satisfaction. Failure of OCA was defined as revision OCA or conversion to total knee arthroplasty (TKA). Results Nineteen of 39 knees (49%) had further surgery. Ten knees (26%) were considered OCA failures (3 OCA revisions, 6 TKA, and 1 patellectomy). Survivorship of the OCA was 82.6% at 5 years and 69.6% at 10 years. Among the 29 knees (74%) that had the OCA still in situ, median follow-up was 6.6 years. Pain and function improved from preoperative to latest follow-up83% of patients reported satisfaction with OCA results. Conclusion OCA transplantation is a useful salvage treatment option for osteochondral lesions caused by knee fracture. Although the reoperation rate was high, successful outcome was associated with significant clinical improvement.Univ Fed Sao Paulo, Dept Orthopaed Surg, Sao Paulo, BrazilUniv Sao Paulo, Dept Orthopaed Surg, Fac Med, Sao Paulo, BrazilScripps Clin, Shiley Ctr Orthopaed Res & Educ, La Jolla, CA 92037 USAScripps Clin, Div Orthopaed Surg, 10666 North Torrey Pines Rd,MS 116, La Jolla, CA 92037 USAUniv Fed Sao Paulo, Dept Orthopaed Surg, Sao Paulo, BrazilUniv Sao Paulo, Dept Orthopaed Surg, Fac Med, Sao Paulo, BrazilWeb of Scienc